Franca Centorrino - Publications, H-index & Citations

Franca Centorrino

Johns Hopkins University

34H指数

100论文数

6.2K被引数

收录论文 27

发表时间

The role of weight gain in explaining the effects of antipsychotic drugs on positive and negative symptoms: An analysis of the CATIE schizophrenia trial

SCHIZOPHRENIA RESEARCH

IF3.5

2019-04-01

PREAI

Bellavia, Andrea; Centorrino, Franca; Jackson, John W.; Fitzmaurice, Garrett; Valeri, Linda

The role of PANSS symptoms and adverse events in explaining the effects of paliperidone on social functioning: a causal mediation analysis approach

NPJ SCHIZOPHRENIA

IF5.7

2018-06-27

OAAI

Zou, Xue; Zhu, Yiwen; Jackson, John W.; Bellavia, Andrea; Fitzmaurice, Garrett M.; Centorrino, Franca; Valeri, Linda

Explaining Comparative Efficacy of Antipsychotic Medications: A Causal Mediation Approach

BIOLOGICAL PSYCHIATRY

IF9

2017-05-01

PREAI

Valeri, Linda; Bellavia, Andrea; Centorrino, Franca; Jackson, John; Fitzmaurice, Garrett

Factors associated with length of psychiatric hospitalization

COMPREHENSIVE PSYCHIATRY

IF4.2

2014-04-01

PREAI

Masters, Grace A.; Baldessarini, Ross J.; Oenguer, Dost; Centorrino, Franca

Pilot randomized, controlled trial of pramipexole to augment antipsychotic treatment

EUROPEAN NEUROPSYCHOPHARMACOLOGY

IF6.7

2012-06-01

PREAI

Kelleher, James P.; Centorrino, Franca; Huxley, Nancy A.; Bates, John A.; Drake, Jennifer Kidwell; Egli, Samy; Baldessarini, Ross J.

Characteristics and Clinical Changes during Hospitalization in Bipolar and Psychotic Disorder Patients with versus without Substance-Use Disorders

PHARMACOPSYCHIATRY

IF2.2

2010-07-22

PREAI

Vincenti, A.; Ventriglio, A.; Baldessarini, R. J.; Talamo, A.; Fitzmaurice, G.; Centorrino, F.

International Consensus Study of Antipsychotic Dosing 抗精神病药物剂量的国际共识研究

AMERICAN JOURNAL OF PSYCHIATRY

IF14.7

2010-06-01

1.1K

PREAI

Gardner, David M.; Murphy, Andrea L.; O'Donnell, Heather; Centorrino, Franca; Baldessarini, Ross J.

The prevalence and costs of metabolic conditions among patients with bipolar disorders as compared to matched controls

VALUE IN HEALTH

IF6

2008-05-01

OAAI

Mark, T. L.; Centorrino, F.; Talamo, A.; Oh, K.; Chang, J.

Hospital use of antipsychotic drugs: polytherapy

COMPREHENSIVE PSYCHIATRY

IF4.2

2008-01-01

PREAI

Centorrino, Franca; Cincotta, Stephanie L.; Talamo, Alessandra; Fogarty, Kate V.; Guzzetta, Francesca; Saadeh, Mark G.; Salvatore, Paola; Baldessarini, Ross J.

Reply to Potvin et al. 2006 regarding comorbid substance-use in schizophrenia

SCHIZOPHRENIA RESEARCH

IF3.5

2007-02-01

PREAI

Talamo, Alessandra; Centorrino, Franca; Tondo, Leonardo; Dimitri, Andrea; Baldessarini, Ross J.

Comorbid substance-use in schizophrenia: Relation to positive and negative symptoms

SCHIZOPHRENIA RESEARCH

IF3.5

2006-09-01

PREAI

Talamo, A.; Centorrino, F.; Tondo, L.; Dimitri, A.; Hennen, J.; Baldessarini, R. J.

Monotherapy versus polypharmacy for hospitalized psychiatric patients - Reply

AMERICAN JOURNAL OF PSYCHIATRY

IF14.7

2005-03-01

PREAI

Centorrino, F; Goren, JL; Hennen, J; Salvatore, P; Kelleher, JP; Baldessarini, RJ

Multiple versus single antipsychotic agents for hospitalized psychiatric patients: Case-control study of risks versus benefits

AMERICAN JOURNAL OF PSYCHIATRY

IF14.7

2004-04-01

204

OAAI

Centorrino, F; Goren, JL; Hennen, J; Salvatore, P; Kelleher, JP; Baldessarini, RJ

Oxcarbazepine: clinical experience with hospitalized psychiatric patients

BIPOLAR DISORDERS

IF4.5

2003-10-03

PREAI

Centorrino, F; Albert, MJ; Berry, JM; Kelleher, JP; Fellman, V; Line, G; Koukopoulos, AE; Kidwell, JE; Fogarty, KV; Baldessarini, RJ

Long-term efficacy and safety of atypical and conventional antipsychotic drugs in first episode schizophrenia

EUROPEAN NEUROPSYCHOPHARMACOLOGY

IF6.7

2003-10-01

PREAI

Sharma, T; Lieberman, JA; McEvoy, JP; Perkins, DO; Hamer, RM; Zipursky, RB; Kahn, RS; Gur, RE; Centorrino, F; Glick, I; Green, AI; Nemeroff, CB; Rothschild, AJ; Strakowski, SM; Tohen, M; Tollefson, GD

Pilot comparison of extended-release and standard preparations of divalproex sodium in patients with bipolar and schizoaffective disorders

AMERICAN JOURNAL OF PSYCHIATRY

IF14.7

2003-07-01

PREAI

Centorrino, F; Kelleher, JP; Berry, JM; Salvatore, P; Eakin, M; Fogarty, KV; Fellman, V; Baldessarini, RJ

Drug attitudes and treatment adherence in a clinical trial comparing haloperidol and olanzapine in first episode schizophrenia

SCHIZOPHRENIA RESEARCH

IF3.5

2003-03-01

PREAI

Centorrino, F; Hamer, RM; Tohen, M; Lieberman, JA

Pramipexole augments benefits of atypical antipsychotics in patients with schizophrenia or schizoaffective disorder

SCHIZOPHRENIA RESEARCH

IF3.5

2003-03-01

PREAI

Kelleher, JP; Centorrino, F; Huxley, NA; Hennen, J; Eakin, M; Kidwell, J; Egli, S; Berry, JM; Fogarty, KV; Fellman, VH; Baldessarini, RJ

Long-term efficacy and safety of atypical and conventional antipsychotic drugs in first episode schizophrenia

SCHIZOPHRENIA RESEARCH

IF3.5

2003-03-01

PREAI

McEvoy, J; Lieberman, JA; Perkins, D; Hamer, RM; Sharma, T; Zipursky, R; Kahn, R; Gur, R; Centorrino, F; Glick, I; Green, AI; Nemeroff, C; Rothschild, A; Strakowski, S; Tohen, M; Tollefson, GD

Inpatient antipsychotic drug use in 1998, 1993, and 1989

AMERICAN JOURNAL OF PSYCHIATRY

IF14.7

2002-11-01

OAAI

Centorrino, F; Eakin, M; Bahk, WM; Kelleher, JP; Goren, J; Salvatore, P; Egli, S; Baldessarini, RJ

研究方向